219982-82-8

Basic information

• Product Name: 7-octyne-1-yl 4-methylbenzene sulfonate
• Synonyms: 7-octyne-1-yl 4-methylbenzene sulfonate
• CAS NO: 219982-82-8
• Molecular Weight: 280.388
• Mol File: 219982-82-8.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 7-octyne-1-yl 4-methylbenzene sulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: 7-octyne-1-yl 4-methylbenzene sulfonate(219982-82-8)
• EPA Substance Registry System: 7-octyne-1-yl 4-methylbenzene sulfonate(219982-82-8)

Safety Data

• Hazardous Substances Data: 219982-82-8(Hazardous Substances Data)

Upstream product

• 871-91-0 oct-7-yn-1-ol 
• 98-59-9 p-toluenesulfonyl chloride 
• 104-15-4 toluene-4-sulfonic acid 
• 14916-80-4 oct-3-yn-1-ol 

Downstream Products

• 186670-53-1 methyl 2-methoxy-6-(8-nonynyl)benzoate 
• 81216-13-9 8-bromooct-1-yne 

Relevant articles and documents

Synthesis of 5-(carboranylalkylmercapto)-2'-deoxyuridines and 3- (carboranylalkyl)thymidines and their evaluation as substrates for human thymidine kinases 1 and 2

Derivatives of thymidine containing o-carboranylalkyl groups at the N-3 position and derivatives of 2'-deoxyuridine containing o- carboranylalkylmercapto groups at the C-5 position were synthesized. The alkyl spacers consist of 4-8 methylene units. The sy

NOVEL LYSOPHOSPHATIDIC ACID DERIVATIVE

PROBLEM TO BE SOLVED: To provide a compound that specifically activates an LPA4 receptor, and a pharmaceutical composition containing the same. SOLUTION: This invention relates to a novel lysophosphatidic acid derivative that has an agonistic action on an LPA4 receptor and is useful for the prevention and/or treatment of a disease with angiodysplasia caused by the LPA4 receptor, or a disease associated with angiopathy, or symptoms associated therewith. This invention also relates to a pharmaceutical composition containing the lysophosphatidic acid derivative. SELECTED DRAWING: None COPYRIGHT: (C)2021,JPOandINPIT

Fused ring aziridines as a facile entry into triazole fused tricyclic and bicyclic heterocycles

The intramolecular dipolar cycloaddition of an azide with an alkyne has provided a useful entry into triazole fused tricyclic heterocycles containing both the triazole ring and the oxazolidin-2-one ring system. The requisite azido-alkynes have been prepared via a two-step sequence from fused ring aziridines. A series of 6-12 membered rings containing both the oxazolidinone and triazole rings have been prepared. These ring systems have been designed as conformationally restrained analogs of RNA-binding oxazolidinones. The Royal Society of Chemistry 2012.